Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma

Figure 1 Duration from initial curative therapy for hepatocellular carcinoma to hepatocellular carcinoma recurrence in the different region. A: The period until developing a new lesion in a remote location of the liver was significantly longer in the postprandial glucose within 200 mg/dL group with diabetes mellitus than in the postprandial glucose > 200 mg/dL group without local recurrence after initial therapy for hepatocellular carcinoma (HCC) (log-rank test, P < 0.05); B: There was no difference in the period between the non-alcohol group with a history of drinking and the continuation group without local recurrence after initial curative therapy for HCC.